Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis

Neuroscience Letters

Volumn 425, Issue 3, 2007, Pages 173-176

  Scalabrini, Diego ^a   Fenoglio, Chiara ^a   Scarpini, Elio ^a   De Riz, Milena ^a   Comi, Cristoforo ^b,c   Venturelli, Eliana ^a   Cortini, Francesca ^a   Piola, Mirko ^a   Villa, Chiara ^a   Naldi, Paola ^b   Monaco, Francesco ^b,c   Bresolin, Nereo ^a   Galimberti, Daniela ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Haplotype; Multiple sclerosis (MS); Single nucleotide polymorphism (SNP); SPARCL1

Indexed keywords

ASPARTIC ACID; HISTIDINE; PROTEIN SPARCL1; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE COURSE; EXON; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CALCIUM-BINDING PROTEINS; DNA MUTATIONAL ANALYSIS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX DISTRIBUTION; SEX FACTORS;

EID: 34548671844     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.08.020     Document Type: Article

References (26)

1. Ballerini C., Guerini F.R., Rombola G., Rosati E., Massacesi L., Ferrante P., Caputo D., Talamanca L.F., Naldi P., Liguori M., Alizadeh M., Momigliano-Richiardi P., and D'Alfonso S. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J. Neuroimmunol. 150 (2004) 178-185
2. Barcellos L.F., Oksenberg J.R., Begovich A.B., Martin E.R., Schmidt S., Vittinghoff E., Goodin D.S., Pelletier D., Lincoln R.R., Bucher P., Swerdlin A., Pericak-Vance M.A., Haines J.L., Hauser S.L., and Multiple Sclerosis Genetics Group. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am. J. Hum. Genet. 72 (2003) 710-716
3. Bendik I., Schraml P., and Ludwig C.U. Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancer. Cancer Res. 58 (1998) 626-629
4. Bornstein P., and Sage E.H. Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell Biol. 14 (2002) 608-616
5. Claeskens A., Ongenae N., Neefs J.M., Cheyns P., Kaijen P., Cools M., and Kutoh E. Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. Br. J. Cancer 82 (2000) 1123-1130
6. Esposito I., Kayed H., Keleg S., Giese T., Sage E.H., Schirmacher P., Friess H., and Kleeff J. Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer. Neoplasia 9 (2007) 8-17
7. Fenoglio C., Galimberti D., Ban M., Maranian M., Scalabrini D., Venturelli E., Piccio L., De Riz M., Yeo T.W., Goris A., Gray J., Bresolin N., Scarpini E., Compston A., and Sawcer S. SELPLG and SELP single-nucleotide polymorphisms in multiple sclerosis. Neurosci. Lett. 394 (2006) 92-96
8. Flachenecker P. Epidemiology of neuroimmunological diseases. J. Neurol. 253 Suppl. 5 (2006) v2-v8
9. Galimberti D., Bresolin N., and Scarpini E. Chemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments. Expert Rev. Neurother. 4 (2004) 439-453
10. Galimberti D., Fenoglio C., Clerici R., Comi C., De Riz M., Rottoli M., Piccio L., Ronzoni M., Venturelli E., Monaco F., Poloni M., Bresolin N., and Scarpini E. E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis. J. Neuroimmunol. 165 (2005) 201-205
11. Galimberti D., Scalabrini D., Fenoglio C., Comi C., De Riz M., Venturelli E., Lovati C., Mariani C., Monaco F., Bresolin N., and Scarpini E. CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course. Eur. J. Neurol. 14 (2007) 162-167
12. Girard J.P., and Springer T.A. Cloning from purified high endothelial venule cells of hevin, a close relative of the antiadhesive extracellular matrix protein SPARC. Immunity 2 (1995) 113-123
13. Girard J.P., and Springer T.A. Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules. J. Biol. Chem. 271 (1996) 4511-4517
14. Gongidi V., Ring C., Moody M., Brekken R., Sage E.H., Rakic P., and Anton E.S. SPARC-like 1 regulates the terminal phase of radial glia-guided migration in the cerebral cortex. Neuron 41 (2004) 57-69
15. Hammack B.N., Fung K.Y., Hunsucker S.W., Duncan M.W., Burgoon M.P., Owens G.P., and Gilden D.H. Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult. Scler. 10 (2004) 245-260
16. Isler S.G., Ludwig C.U., Chiquet-Ehrismann R., and Schenk S. Evidence for transcriptional repression of SPARC-like 1, a gene downregulated in human lung tumors. Int. J. Oncol. 25 (2004) 1073-1079
17. Kantarci O.H., Goris A., Hebrink D.D., Heggarty S., Cunningham S., Alloza I., Atkinson E.J., de Andrade M., McMurray C.T., Graham C.A., Hawkins S.A., Billiau A., Dubois B., Weinshenker B.G., and Vandenbroeck K. IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis. Genes Immun. 6 (2005) 153-161
18. Lublin F.D., Reingold S.C., and the National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis; results of an international survey. Neurology 46 (1996) 907-911
19. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., and Wolinsky J.S. Recommended diagnostic criteria for MS. Ann. Neurol. 50 (2001) 121-127
20. Nelson P.S., Plymate S.R., Wang K., True L.D., Ware J.L., Gan L., Liu A.Y., and Hood L. Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. Cancer Res. 58 (1998) 232-236
21. Piccio L., Rossi B., Scarpini E., Laudanna C., Giagulli C., Issekutz A.C., Vestweber D., Butcher E.C., and Constantin G. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric Gi-linked receptors. J. Immunol. 168 (2002) 1940-1949
22. Scalabrini D., Galimberti D., Fenoglio C., Comi C., De Riz M., Venturelli E., Castelli L., Piccio L., Ronzoni M., Lovati C., Mariani C., Monaco F., Bresolin N., and Scarpini E. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis. Neurosci. Lett. 388 (2005) 149-152
23. Schrijver H.M., Crusius J.B., Garcia-Gonzalez M.A., Polman C.H., Pena A.S., Barkhof F., and Uitdehaag B.M. Gender-related association between the TGFB1 + 869 polymorphism and multiple sclerosis. J. Interferon Cytokine Res. 24 (2004) 536-542
24. St Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., and Kinzler K.W. Genes expressed in human tumor endothelium. Science 289 (2000) 1197-1202
25. Sullivan M.M., and Sage E.H. Hevin/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family. Int. J. Biochem. Cell Biol. 36 (2004) 991-996
26. The International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320